Home > News > First of her kind: Brenner named head of NanoLife Initiatives at UAlbany
June 1st, 2009
First of her kind: Brenner named head of NanoLife Initiatives at UAlbany
Abstract:
Can you imagine a world in which microscopic particles, invisible to the naked eye, are used to repair skin tissue damaged by burns or cuts? Or a world in which those who need organ replacements no longer have to wait in line for the next available donor?
Dr. Sara Brenner does. And, even though it's a bit too sci-fi for today's world, a new world is dawning in Albany, N.Y. To get there, however, she had to give up an once-in-a-lifetime opportunity to take her dream job with the federal government.
Alain Kaloyeros, senior vice president of the College of Nanoscale Science and Engineering at the university, offered Brenner to be among the first in her field of work. It was an opportunity to place her self at the cutting edge of medicine, science and nanotechnology.
Brenner accepted a faculty position at the CNSE, a $4.5 billion megaplex dedicated to expanding nanotechnology's use in everyday life. She will be Assistant Vice President for NanoLife Intiatives, and an assistant professor of bioscience, making her the college's first physician faculty member.
"My focus will be to apply nanotechnology to life science, health care, dentistry, pharmaceuticals and botany. Nanotechnology is the manipulation of matter at its smallest levels to change its physical and chemical properties," she said. "My charge will be to fill the gap between research and actual applications."
Source:
amestrib.com
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Sensors
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||